Dynamic functional connectivity patterns associated with dementia risk.

Cardiovascular risk factors Cognition Cognitive reserve Dementia risk Dynamic functional network connectivity Lifestyle Sliding window analysis

Journal

Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643

Informations de publication

Date de publication:
23 05 2022
Historique:
received: 12 01 2022
accepted: 06 04 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 26 5 2022
Statut: epublish

Résumé

This study assesses the relationships between dynamic functional network connectivity (DFNC) and dementia risk. DFNC of the default mode (DMN), salience (SN), and executive control networks was assessed in 127 cognitively unimpaired older adults. Stepwise regressions were performed with dementia risk and protective factors and biomarkers as predictors of DFNC. Associations were found between times spent in (i) a "weakly connected" state and lower self-reported engagement in early- and mid-life cognitive activity and higher LDL cholesterol; (ii) a "SN-negatively connected" state and higher blood pressure, higher depression score, and lower body mass index (BMI); (iii) a "strongly connected" state and higher self-reported engagement in early-life cognitive activity, Preclinical Alzheimer's cognitive composite-5 score, and BMI; and (iv) a "DMN-negatively connected" state and higher self-reported engagement in early- and mid-life stimulating activities and lower LDL cholesterol and blood pressure. The lower number of state transitions was associated with lower brain perfusion. DFNC states are differentially associated with dementia risk and could underlie reserve.

Sections du résumé

BACKGROUND
This study assesses the relationships between dynamic functional network connectivity (DFNC) and dementia risk.
METHODS
DFNC of the default mode (DMN), salience (SN), and executive control networks was assessed in 127 cognitively unimpaired older adults. Stepwise regressions were performed with dementia risk and protective factors and biomarkers as predictors of DFNC.
RESULTS
Associations were found between times spent in (i) a "weakly connected" state and lower self-reported engagement in early- and mid-life cognitive activity and higher LDL cholesterol; (ii) a "SN-negatively connected" state and higher blood pressure, higher depression score, and lower body mass index (BMI); (iii) a "strongly connected" state and higher self-reported engagement in early-life cognitive activity, Preclinical Alzheimer's cognitive composite-5 score, and BMI; and (iv) a "DMN-negatively connected" state and higher self-reported engagement in early- and mid-life stimulating activities and lower LDL cholesterol and blood pressure. The lower number of state transitions was associated with lower brain perfusion.
CONCLUSION
DFNC states are differentially associated with dementia risk and could underlie reserve.

Identifiants

pubmed: 35606867
doi: 10.1186/s13195-022-01006-7
pii: 10.1186/s13195-022-01006-7
pmc: PMC9128270
doi:

Substances chimiques

Cholesterol, LDL 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

72

Investigateurs

Eider M Arenaza-Urquijo (EM)
Florence Allais (F)
Claire André (C)
Julien Asselineau (J)
Alexandre Bejanin (A)
Pierre Champetier (P)
Gaël Chételat (G)
Anne Chocat (A)
Sophie Dautricourt (S)
Robin de Flores (R)
Marion Delarue (M)
Stéphanie Egret (S)
Francesca Felisatti (F)
Eglantine Ferrand Devouge (EF)
Eric Frison (E)
Julie Gonneaud (J)
Marc Heidmann (M)
Thien Huong Tran (TH)
Elizabeth Kuhn (E)
Gwendoline le Du (G)
Brigitte Landeau (B)
Valérie Lefranc (V)
Antoine Lutz (A)
Florence Mezenge (F)
Inès Moulinet (I)
Valentin Ourry (V)
Cassandre Palix (C)
Léo Paly (L)
Géraldine Poisnel (G)
Anne Quillard (A)
Géraldine Rauchs (G)
Stéphane Rehel (S)
Florence Requier (F)
Edelweiss Touron (E)
Denis Vivien (D)
Caitlin Ware (C)
Sebastian Baez Lugo (SB)
Olga Klimecki (O)
Patrik Vuilleumier (P)
Thorsten Barnhofer (T)
Fabienne Collette (F)
Eric Salmon (E)
Vincent de la Sayette (V)
Pascal Delamillieure (P)
Martine Batchelor (M)
Axel Beaugonin (A)
Francis Gheysen (F)
Harriet Demnitz-King (H)
Natalie Marchant (N)
Tim Whitfield (T)
Corinne Schimmer (C)
Miranka Wirth (M)

Informations de copyright

© 2022. The Author(s).

Références

J Clin Exp Neuropsychol. 2003 Aug;25(5):634-42
pubmed: 12815501
Trends Cogn Sci. 2011 Oct;15(10):483-506
pubmed: 21908230
Alzheimers Dement (N Y). 2018 Dec 14;4:714-723
pubmed: 30581977
Hum Brain Mapp. 2019 Oct 15;40(15):4564-4576
pubmed: 31379120
Neurology. 2009 May 19;72(20):1741-6
pubmed: 19451529
Neurobiol Aging. 2019 Nov;83:124-129
pubmed: 31732015
Biol Psychiatry. 2014 Aug 1;76(3):258-66
pubmed: 24387823
Hum Brain Mapp. 2019 Aug 15;40(12):3431-3451
pubmed: 31034738
Lancet Neurol. 2012 Nov;11(11):1006-12
pubmed: 23079557
J Int Neuropsychol Soc. 2005 Jul;11(4):400-7
pubmed: 16209420
JAMA Neurol. 2020 Jun 1;77(6):716-724
pubmed: 32202593
J Neurosci. 2014 Jan 8;34(2):451-61
pubmed: 24403145
Brain. 2020 Mar 1;143(3):993-1009
pubmed: 32203580
JAMA. 2019 Aug 13;322(6):535-545
pubmed: 31408138
Neuron. 2018 Feb 21;97(4):940-952.e4
pubmed: 29398365
Hum Brain Mapp. 2016 Sep;37(9):3310-22
pubmed: 27144904
Neuron. 2014 Oct 22;84(2):262-74
pubmed: 25374354
Neurology. 2017 Jul 4;89(1):29-37
pubmed: 28592457
Neuroimage. 2019 Feb 1;186:690-702
pubmed: 30503934
J Prev Alzheimers Dis. 2021;8(3):313-321
pubmed: 34101789
J Clin Epidemiol. 1993 Feb;46(2):153-62
pubmed: 8437031
Neuroimage. 2017 Oct 15;160:41-54
pubmed: 28034766
Neuroimage Clin. 2020;28:102375
pubmed: 32961402
Neuroimage. 2021 May 1;231:117832
pubmed: 33549747
Psychol Med. 2007 Jul;37(7):1015-25
pubmed: 17112402
J Alzheimers Dis. 2014;38(1):201-9
pubmed: 23948937
Neuroimage. 2013 Apr 1;69:157-97
pubmed: 23194820
Neurology. 2017 Dec 12;89(24):2447-2454
pubmed: 29117954
Hum Brain Mapp. 2019 Aug 1;40(11):3203-3221
pubmed: 30950567
Alzheimers Dement (Amst). 2017 Jun 20;8:165-178
pubmed: 28761927
J Neurosci. 2015 Jul 08;35(27):10015-24
pubmed: 26157001
Percept Mot Skills. 1991 Dec;73(3 Pt 1):1032
pubmed: 1792116
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Alzheimers Dement. 2018 May;14(5):601-609
pubmed: 29169013
Sci Rep. 2017 Jan 11;7:40268
pubmed: 28074926
Clin Neurophysiol. 2018 Jan;129(1):198-207
pubmed: 29190525
Neuroimage Clin. 2019;22:101812
pubmed: 30991620
Front Neural Circuits. 2021 Jan 21;14:593263
pubmed: 33551754
JAMA Neurol. 2019 Oct 01;76(10):1184-1191
pubmed: 31302677
J Alzheimers Dis. 2015;50(2):455-63
pubmed: 26682694
Cereb Cortex. 2012 Jan;22(1):158-65
pubmed: 21616982
Neuroimage Clin. 2019;22:101747
pubmed: 30921608
CNS Neurosci Ther. 2020 Sep;26(9):962-971
pubmed: 32378335
Neuroimage Clin. 2017 Dec 09;17:847-855
pubmed: 29527489
Psychiatry Res. 2014 Apr 30;222(1-2):29-36
pubmed: 24656767
Cereb Cortex. 2014 Mar;24(3):663-76
pubmed: 23146964
Neuroimage. 2001 Nov;14(5):1080-8
pubmed: 11697939
Soc Cogn Affect Neurosci. 2021 Aug 5;16(8):849-874
pubmed: 32785604
Neuropsychologia. 2009 Aug;47(10):2015-28
pubmed: 19467352
Sci Rep. 2017 Jul 11;7(1):5135
pubmed: 28698644
Acta Neuropathol. 2014 Jan;127(1):137-50
pubmed: 24356982
Alzheimers Dement (N Y). 2017 Nov 10;3(4):668-677
pubmed: 29264389

Auteurs

Sophie Dautricourt (S)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.
Neurology Department, University Hospital, Caen, France.

Julie Gonneaud (J)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Brigitte Landeau (B)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Vince D Calhoun (VD)

Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of Technology, Emory University, Atlanta, GA, USA.

Robin de Flores (R)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Géraldine Poisnel (G)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Salma Bougacha (S)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Valentin Ourry (V)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.
Inserm U1077, Caen-Normandie University, École Pratique des Hautes Études, Caen, France.

Edelweiss Touron (E)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Elizabeth Kuhn (E)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Harriet Demintz-King (H)

Division of Psychiatry, Faculty of Brain Sciences, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London, W1T7NF, UK.

Natalie L Marchant (NL)

Division of Psychiatry, Faculty of Brain Sciences, University College London, 6th Floor, Maple House, 149 Tottenham Court Road, London, W1T7NF, UK.

Denis Vivien (D)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France.

Vincent de la Sayette (V)

Neurology Department, University Hospital, Caen, France.
Inserm U1077, Caen-Normandie University, École Pratique des Hautes Études, Caen, France.

Antoine Lutz (A)

Lyon Neuroscience Research Center INSERM U1028, CNRS UMR 5292, Lyon University, Lyon, France.

Gaël Chételat (G)

Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France. chetelat@cyceron.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH